As technology and life sciences companies' exposures evolve, their overall risk management strategy must adapt in lockstep. (Photo: Chokniti Khongchum/Shutterstock)
Technology and life sciences companies have proven resilient as they navigated challenges and disruptions during the COVID-19 pandemic, while finding opportunities to expand their businesses. These innovators helped the world adapt since the onset of the pandemic. They also made operational adjustments that may have created new risks and unintended exposures.
Want to continue reading?
Become a Free PropertyCasualty360 Digital Reader
Your access to unlimited PropertyCasualty360 content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking insurance news and analysis, on-site and via our newsletters and custom alerts
- Weekly Insurance Speak podcast featuring exclusive interviews with industry leaders
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the employee benefits and financial advisory markets on our other ALM sites, BenefitsPRO and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
